Gary Charles Robb, Chief Business Officer at CORCEPT THERAPEUTICS INC (CORT), sold 11,000 shares at $46.28 ($509K) on 2024-10-01, disclosed to the SEC on 2024-10-01.
Scheduled sale ($509k) by Chief Business Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| CORT | SELL | 2025-06-18 | $451K | — | Filing → |
| CORT | SELL | 2025-05-22 | $346K | — | Filing → |
| CORT | SELL | 2025-01-06 | $556K | — | Filing → |